Study Says Predictive Whole-Genome Sequencing Is Probably Not Very Useful | GenomeWeb

While whole-genome sequencing has proven useful for studying disease, it is less likely to be useful in predicting whether a healthy individual will develop a disease, a study recently published in Science Translational Medicine suggests. At the annual meeting of the American Association for Cancer Research in Chicago last month, Johns Hopkins Kimmel Cancer Center's Bert Vogelstein described the study done by his team. "Many believe, I among them, that we stand on the verge of a revolution," Vogelstein said at an AACR press conference.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.